Close Menu

RT-PCR

A National Institutes of Health team demonstrated EBOV RNA can be found in semen using strategies approved for finding the virus in blood.

The first tranche of the targeted $20 million financing round will be used to accelerate adoption of the company's melanoma test.

A new study has found that an antigen-based rapid diagnostic test for Ebola could be more reliable under certain circumstances than a recently approved RT-PCR assay for the virus.

Clinicians at the recent ASCO noted that more practical and accurate molecular diagnostics are approaching the clinic alongside novel targeted drug regimens.

Authors of the Ontario study said that their survey suggests the need for clinical guidelines to standardize use of the test among oncologists and for resources to improve patients' understanding of results.

The results suggest AR-V7-postive patients should be treated with chemotherapy over AR-directed hormonal therapies to which they are highly resistant.

The NICE recommendation specifies the use of Oncotype DX for intermediate risk patients for whom doctors are unclear whether to prescribe chemotherapy.

The study demonstrated that the company's DecisionDx-Melanoma assay better predicts the risk of metastasis in patients with localized disease than clinical staging alone.

Freeze-drying and rehydrating pooled samples may overcome problems casued by dilution of pathogen nucleic acids.

Tiny transcript shifts across mouse and human cell types led researchers to alternatively splice neural microexons that may be misregulated in post-mortem brain tissues from individuals with autism spectrum disorder.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.